Pulse pressure and stroke risk: development and validation of a new stroke risk model
Abstract Objective: This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental...
Saved in:
Published in: | Current medical research and opinion Vol. 30; no. 12; pp. 2453 - 2460 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Informa UK Ltd
01-12-2014
Taylor & Francis |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Abstract
Objective:
This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP.
Methods:
Electronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with 1 PP reading and 6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic.
Results:
Among 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor.
Limitations:
This study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration.
Conclusions:
This stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies. |
---|---|
AbstractList | OBJECTIVEThis study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP.METHODSElectronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with ≥ 1 PP reading and ≥ 6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic.RESULTSAmong 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor.LIMITATIONSThis study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration.CONCLUSIONSThis stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies. Abstract Objective: This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP. Methods: Electronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with 1 PP reading and 6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic. Results: Among 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor. Limitations: This study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration. Conclusions: This stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies. This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP. Electronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with ≥1 PP reading and ≥6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic. Among 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor. This study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration. This stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies. This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP, defined as the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP), could be an incremental risk factor beyond SBP. Electronic health records (EHRs) of hypertensive patients from a US integrated health delivery system were analyzed (January 2004 to May 2012). Patients with ≥ 1 PP reading and ≥ 6 months of observation prior to the first diagnosis of hypertension were randomly split into development (two-thirds of sample) and validation (one-third of sample) datasets. Stroke events were identified using ICD-9-CM 433.xx-436.xx. Cox proportional hazards models assessed time to first stroke event within 3 years of first hypertension diagnosis based on baseline risk factors, including PP, age, gender, diabetes, and cardiac comorbidities. The optimal model was selected using the least absolute shrinkage and selection operator (LASSO); performance was evaluated by the c-statistic. Among 34,797 patients selected (mean age 59.3 years, 48% male), 4272 patients (12.3%) had a stroke. PP was higher among patients who developed stroke (mean [SD] PP, stroke: 02.0 [15.3] mmHg; non-stroke: 58.1 [14.0] mmHg, p < 0.001). The best performing risk model (c-statistic, development: 0.730; validation: 0.729) included PP (hazard ratio per mmHg increase: 1.0037, p < 0.001) as a significant risk factor. This study was subject to limitations similar to other studies using EHRs. Only patient encounters occurring within the single healthcare network were captured in the data source. Though the model was tested internally, external validation (using a separate data source) would help assess the model's generalizability and calibration. This stroke risk model shows that greater PP is a significant predictive factor for increased stroke risk, even in the presence of known risk factors. PP should be considered by practitioners along with established risk factors in stroke treatment strategies. |
Author | Ayyagari, Rajeev Vekeman, Francis Machnicki, Gerardo Lefebvre, Patrick Duh, Mei Sheng Trahey, Alex Ong, Siew Hwa Faust, Elizabeth |
Author_xml | – sequence: 1 givenname: Rajeev surname: Ayyagari fullname: Ayyagari, Rajeev email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com organization: Analysis Group Inc – sequence: 2 givenname: Francis surname: Vekeman fullname: Vekeman, Francis email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com organization: Groupe d'analyse Ltée – sequence: 3 givenname: Patrick surname: Lefebvre fullname: Lefebvre, Patrick email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com organization: Groupe d'analyse Ltée – sequence: 4 givenname: Siew Hwa surname: Ong fullname: Ong, Siew Hwa email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com organization: Novartis Pharma AG – sequence: 5 givenname: Elizabeth surname: Faust fullname: Faust, Elizabeth email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com organization: Analysis Group Inc – sequence: 6 givenname: Alex surname: Trahey fullname: Trahey, Alex email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com organization: Analysis Group Inc – sequence: 7 givenname: Gerardo surname: Machnicki fullname: Machnicki, Gerardo email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com organization: Novartis Argentina SA – sequence: 8 givenname: Mei Sheng surname: Duh fullname: Duh, Mei Sheng email: Mei.Duh@analysisgroup.com, Mei.Duh@analysisgroup.com organization: Analysis Group Inc |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25265131$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkE1P3DAQhq2Kqiwf_wBVPvaSrcdO4oQDFUL9kpDKAc7WrD0RAcde7ATEv2-2C6hc4DSHed53Rs8e2wkxEGNHIJYATfVVKCF021ZLKaBcthpUpT-wBZRaFWWj9Q5bbJBiw-yyvZxvhADZtO0ntisrWVegYMGuLiafia8T5Twl4hgcz2OKt8RTn2-PuaN78nE9UBj_Le_R9w7HPgYeO4480MP_AT5ER_6Afexw7j18mvvs6sf3y7Nfxfmfn7_PTs8LW0IzFtgikFXSrqSlrm6p1sIpWQpU2kJDzoFrbT1TQoMtydVSWmexdF1tV4hqn33Z9q5TvJsoj2bosyXvMVCcsoFaNk0DIOoZLbeoTTHnRJ1Zp37A9GhAmI1Q8yzUbISardA59vnpwrQayL2Eng3OwLct0IcupgEfYvLOjPjoY-oSBttno945cfKq4ZrQj9cWE5mbOKUwC3z7x78_B5tg |
CitedBy_id | crossref_primary_10_1093_jamia_ocw042 crossref_primary_10_1161_JAHA_118_010811 crossref_primary_10_1097_HJH_0000000000001268 crossref_primary_10_1155_2022_6956406 crossref_primary_10_1097_HJH_0000000000002442 crossref_primary_10_1097_MD_0000000000009233 crossref_primary_10_1093_ajh_hpx025 crossref_primary_10_1007_s10143_023_02256_1 crossref_primary_10_1016_j_ijmedinf_2020_104272 crossref_primary_10_1155_2023_5517493 crossref_primary_10_1007_s00392_016_0972_2 crossref_primary_10_1097_JCN_0000000000000541 |
Cites_doi | 10.1038/ki.2012.131 10.1161/hy1001.092966 10.1093/ajh/hps092 10.1161/01.CIR.96.1.308 10.1001/jama.1982.03320300037019 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3 10.1016/0002-9149(76)90061-8 10.1016/S0895-4356(01)00434-6 10.1161/CIRCULATIONAHA.108.823112 10.1161/01.STR.22.3.312 10.1161/01.HYP.34.3.375 10.1097/00004872-200018040-00010 10.1161/STR.0b013e3181fcb238 10.1161/01.STR.11.1.14 10.1001/archinte.160.8.1085 10.1161/01.HYP.23.3.395 10.1093/eurheartj/eht151 10.1001/jama.284.7.876 10.1161/01.HYP.0000145108.23948.7b 10.1161/CIR.0b013e31823ac046 10.1161/01.HYP.38.2.232 10.2307/3349563 10.1038/sj.jhh.1001669 10.1161/01.CIR.103.21.2579 10.1016/S0895-7061(01)02044-1 10.1161/CIRCULATIONAHA.111.069633 10.1161/HYPERTENSIONAHA.112.201400 10.1002/sim.4154 10.1161/01.CIR.100.4.354 |
ContentType | Journal Article |
Copyright | 2014 All rights reserved: reproduction in whole or part not permitted 2014 |
Copyright_xml | – notice: 2014 All rights reserved: reproduction in whole or part not permitted 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1185/03007995.2014.971357 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-4877 |
EndPage | 2460 |
ExternalDocumentID | 10_1185_03007995_2014_971357 25265131 971357 |
Genre | Research Articles Validation Studies Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 00X 03L 08R 0BK 0R~ 29F 34G 39C 3V. 4.4 53G 5GY 5RE 6J9 6PF 7X7 88E 88I 8AF 8AO 8FI 8FJ 8R4 8R5 AAJNR AALIY AALUX AAMIU AAPUL AAPXX AAQRR AAUGY AAWTL ABBAB ABBKH ABEIZ ABIVO ABLJU ABLKL ABOCM ABPTK ABUPF ABUWG ABWCV ABZEW ACENM ACFUF ACGFO ACGFS ACGOD ACKZS ACLSK ADBBV ADCVX ADFCX ADFOM ADFZZ ADRBQ AECIN AEIIZ AENEX AEOZL AEYQI AFKRA AFLEI AFWLO AGDLA AGFJD AGRBW AGYJP AHMBA AIJEM AIRBT AJVHN AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AMDAE AZQEC BABNJ BENPR BLEHA BOHLJ BPHCQ BRMBE BVXVI CAG CCCUG COF CS3 CYYVM CZDIS DKSSO DRXRE DU5 DWQXO DWTOO EBS EJD F5P FYUFA GNUQQ H13 HCIFZ HZ~ IPNFZ J5H JENTW KRBQP KSSTO KWAYT KYCEM L7B LJTGL M1P M2P M2Q M44 M4Z O9- P2P PQEST PQQKQ PQUKI PROAC PSQYO Q2X QQXMO RIG RNANH RVRKI RWL S0X SJN TAE TFDNU TFL TFW UEQFS UKHRP V1S X7M ZGI ~1N AAORF ABJNI ABLIJ ABXYU ACIEZ ALIPV ALYBC CCPQU CGR CUY CVF ECM EIF EMOBN HMCUK NPM NUSFT TBQAZ TDBHL TERGH TUROJ AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c418t-a9a1ec32cb2cef69e670d3240a37c18edd1d9c69a1071c4ed622cdca4df6cbaa3 |
ISSN | 0300-7995 |
IngestDate | Fri Oct 25 06:43:31 EDT 2024 Thu Nov 21 21:56:57 EST 2024 Tue Oct 15 23:48:46 EDT 2024 Tue Jun 13 20:00:57 EDT 2023 Wed Jun 21 08:14:28 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Hypertension Pulse pressure Risk prediction Stroke |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c418t-a9a1ec32cb2cef69e670d3240a37c18edd1d9c69a1071c4ed622cdca4df6cbaa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25265131 |
PQID | 1628881106 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | informahealthcare_journals_10_1185_03007995_2014_971357 pubmed_primary_25265131 proquest_miscellaneous_1628881106 informaworld_taylorfrancis_310_1185_03007995_2014_971357 crossref_primary_10_1185_03007995_2014_971357 |
PublicationCentury | 2000 |
PublicationDate | 20141200 12/1/2014 2014-Dec 2014-12-01 20141201 |
PublicationDateYYYYMMDD | 2014-12-01 |
PublicationDate_xml | – month: 12 year: 2014 text: 20141200 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Current medical research and opinion |
PublicationTitleAlternate | Curr Med Res Opin |
PublicationYear | 2014 |
Publisher | Informa UK Ltd Taylor & Francis |
Publisher_xml | – name: Informa UK Ltd – name: Taylor & Francis |
References | CIT0030 CIT0010 CIT0012 CIT0011 The Australian therapeutic trial in mild hypertension (CIT0009) 1980; 1 CIT0014 CIT0013 CIT0016 CIT0015 CIT0018 CIT0017 CIT0019 CIT0021 CIT0020 CIT0001 CIT0023 CIT0022 Uno H (CIT0025) 2011; 30 CIT0003 CIT0002 CIT0024 CIT0005 CIT0027 CIT0004 CIT0026 CIT0007 CIT0029 CIT0006 CIT0028 CIT0008 |
References_xml | – ident: CIT0019 doi: 10.1038/ki.2012.131 – ident: CIT0015 doi: 10.1161/hy1001.092966 – ident: CIT0012 doi: 10.1093/ajh/hps092 – ident: CIT0013 doi: 10.1161/01.CIR.96.1.308 – ident: CIT0008 doi: 10.1001/jama.1982.03320300037019 – ident: CIT0024 doi: 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3 – ident: CIT0004 doi: 10.1016/0002-9149(76)90061-8 – ident: CIT0023 doi: 10.1016/S0895-4356(01)00434-6 – ident: CIT0029 doi: 10.1161/CIRCULATIONAHA.108.823112 – volume: 1 start-page: 1261 year: 1980 ident: CIT0009 publication-title: Lancet contributor: fullname: The Australian therapeutic trial in mild hypertension – ident: CIT0022 doi: 10.1161/01.STR.22.3.312 – ident: CIT0020 doi: 10.1161/01.HYP.34.3.375 – ident: CIT0027 doi: 10.1097/00004872-200018040-00010 – ident: CIT0001 doi: 10.1161/STR.0b013e3181fcb238 – ident: CIT0005 doi: 10.1161/01.STR.11.1.14 – ident: CIT0021 doi: 10.1001/archinte.160.8.1085 – ident: CIT0016 doi: 10.1161/01.HYP.23.3.395 – ident: CIT0011 doi: 10.1093/eurheartj/eht151 – ident: CIT0026 doi: 10.1001/jama.284.7.876 – ident: CIT0028 doi: 10.1161/01.HYP.0000145108.23948.7b – ident: CIT0002 doi: 10.1161/CIR.0b013e31823ac046 – ident: CIT0030 doi: 10.1161/01.HYP.38.2.232 – ident: CIT0006 doi: 10.2307/3349563 – ident: CIT0018 doi: 10.1038/sj.jhh.1001669 – ident: CIT0010 doi: 10.1161/01.CIR.103.21.2579 – ident: CIT0017 doi: 10.1016/S0895-7061(01)02044-1 – ident: CIT0003 doi: 10.1161/CIRCULATIONAHA.111.069633 – ident: CIT0007 doi: 10.1161/HYPERTENSIONAHA.112.201400 – volume: 30 start-page: 1105 year: 2011 ident: CIT0025 publication-title: Stat Med doi: 10.1002/sim.4154 contributor: fullname: Uno H – ident: CIT0014 doi: 10.1161/01.CIR.100.4.354 |
SSID | ssj0012899 |
Score | 2.2146096 |
Snippet | Abstract
Objective:
This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence... This study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests that PP,... OBJECTIVEThis study aims to develop and validate a stroke risk model incorporating pulse pressure (PP) as a potential risk factor. Recent evidence suggests... |
SourceID | proquest crossref pubmed informaworld informahealthcare |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2453 |
SubjectTerms | Aged Blood Pressure - physiology Electronic Health Records Female Humans Hypertension Hypertension - complications Hypertension - physiopathology Male Middle Aged Proportional Hazards Models Pulse pressure Reproducibility of Results Retrospective Studies Risk Factors Risk prediction Stroke Stroke - etiology Stroke - physiopathology |
Title | Pulse pressure and stroke risk: development and validation of a new stroke risk model |
URI | https://www.tandfonline.com/doi/abs/10.1185/03007995.2014.971357 https://www.ncbi.nlm.nih.gov/pubmed/25265131 https://search.proquest.com/docview/1628881106 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6TUK8oPFdvmQk3lCgcbw44a0aRX3ZQNAh3izHHwOmtWhth_bfc2c7iVn5lniJorjutb5f7s6-L0Ke5KZCS8BkoHxVxmEDkClQDHDXcKZyxozAbOTpO3H4oXo54ZPBoO0c0z_7r5yGZ8BrzJz9C253XwoP4B54DlfgOlz_iO9v1qDsnvrw1tY3sFydLU6sjyLHAwDTxwn5YaD-yXSWo8Im4-mU0CwnNWLbmk6n0ckTCwaFHDlMwEp8--OLC3WsQjr7W_XZ2vN25L09sfH4NXb36IODnG3OY_qZbyHQpRO9jqfbmG4z_arSM4ucX4r_mG20D0mkXjEaZVilLiioIJW5KDLYWYlUbEd3ToQnS4UwD_WHo0JnPHQs2FQWla-rAQSRHob58Wc1tiwUvXLsQhbDwBbZYSDRQKDujPcnhwedwwr3rcFhFX59zNIEEs9_ROA7K2g31sj92EX8Xaqb-_Pdj7eCZrvkWty-0HHA3XUysPMb5MpBDNC4SY48_GgLPwqIoAFLFLH0gibg84M9-OjCUUUBfOkE6sF3ixy9msz2p1ns3JFpnlerTNUqt7pgumHaurK2pRgZLP2oCqHzyhqTm1qX8CmwcDW3pmRMG624caVulCpuk-35Ym7vEsqdc6B3ajA7Ba_hGxtRWVeLorCYo10PSdaupPwSCrRIv7Gt9mS78hJXXoaVHxKxsdwyvr_L38ysUqbIlUexCwCWxa-nPm4ZKEF8o09Oze1iDQSx3XcFNng5JHcCZ7u_wbB1RV7k9_6d8H1ytX__HpDt1dnaPiRbS7N-FBH8DeNywmY |
link.rule.ids | 315,782,786,27933,27934,59868,60657,61275,61456 |
linkProvider | Taylor & Francis |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ZSwMxEB60gvrifdQzgq-r3cNN1reiLRXbIqjgW0hzoAittN3_78xmWy9UEN8WspOQZCYzycx8A3AcGkGWgAlQ-aogwQtAoFAx4FcviVQYRYZTNnLrlncfxGWDYHLqk1wYCqukO7TzQBHFWU3CTY_RXsLF2SkyZo2AzCgyKznJqMocn4U5ghoXFZirXzS6nakrgW4U3pVQC4iozJ_7rp8P-mmlRC99nMZifUI0_d4uLfRTc_kfZrYCS6Vxyuqem1ZhxvbXYL5Tut_X4f4mR03KitjZfGgZjsNG4-Hg2TIKUT9n5i0EqWhENn7yRZvYwDHF0IZ_T8CKOjwbcN9s3F20grIuQ6CTUIwDlanQ6jjSvUhbl2Y25TVDwH4q5joU1pjQZDrFv9B-0Yk1aRRpo1ViXKp7SsWbUOkP-nYbWOKcw1MlQ6OCJxn22OPCuozHsaUM3KwKwWQ35IuH35DFtUWcyclaSVor6deqCvzLlslSKke_UIr3GyvHxYOJ89VNZPwz6dGECSQKJ3lcVN8OchyQijkLtLDSKmx57phOI6LCBGEc7vx94ENYaN112rJ91b3ehUVq8ZE2e1AZD3O7D7Mjkx-UEvEKz1EFqw |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZSwMxEB48oPii9a5nBF9Xu0c3Wd-kB4paBBV8C2kOFKEtbff_O7PZ1gsV9G0hOwmbzGS-2bkAjkMjCAmYAJWvChI0AAKFigGfekmkwigynLKRL-5491G02lQmZ5bFT2GVZEM7XyiiuKtJuIfGeQEXjVPkyzrVMaPArOQkoyZzfB4WEYo30PxaPG-2uzczTwIZFN6TUA-IqEyf-26eD-qpWhYvfZqFYn0qaPo9LC3UU2fl_x9WheUSmrJzz0urMGf7a1C5KZ3v6_Bwm6MeZUXkbD6yDJdh48lo8GIZBaifMfMWgFQMIhM_-5ZNbOCYYojg3xOwogvPBjx02vfNi6DsyhDoJBSTQGUqtDqOdC_S1qWZTXndUFk_FXMdCmtMaDKd4luIXnRiTRpF2miVGJfqnlLxJiz0B327DSxxzuGdkiGk4EmGM_a4sC7jcWwp_zarQTA9DDn0xTdkYbSIhpzulaS9kn6vasC_nJgsZXL8C6V4f65yUvwucb63iYx_Jj2a8oBE0SR_i-rbQY4LUitngfgqrcGWZ47ZZ0TUliCMw52_L3wIldtWR15fdq92YYkGfJjNHixMRrndh_mxyQ9KeXgFhSsETw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pulse+pressure+and+stroke+risk%3A+development+and+validation+of+a+new+stroke+risk+model&rft.jtitle=Current+medical+research+and+opinion&rft.au=Ayyagari%2C+Rajeev&rft.au=Vekeman%2C+Francis&rft.au=Lefebvre%2C+Patrick&rft.au=Ong%2C+Siew+Hwa&rft.date=2014-12-01&rft.pub=Taylor+%26+Francis&rft.issn=0300-7995&rft.eissn=1473-4877&rft.volume=30&rft.issue=12&rft.spage=2453&rft.epage=2460&rft_id=info:doi/10.1185%2F03007995.2014.971357&rft.externalDocID=971357 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-7995&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-7995&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-7995&client=summon |